Evidence map›Paper›PMID 34483091›Full record

ArticleEuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology2022

Transcatheter edge-to-edge mitral valve repair in patients with mitral annulus calcification.

Estefanía Fernández-Peregrina, Isaac Pascual, Xavier Freixa, Gabriela Tirado-Conte, Rodrigo Estévez-Loureiro, Fernando Carrasco-Chinchilla, Tomás Benito-González, Lluis Asmarats, Laura Sanchís, Pilar Jiménez-Quevedo and 9 more

Open access · greenAbstract read
In one paragraph

Article in EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 25 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Prognostic significance of mitral annular calcification assessed by computed tomography for transcatheter edge-to-edge repair outcomes.EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology · 2025
    Observational
  5. Mitral Annular Calcification: Understanding the Disease and Treatment Options.Structural heart : the journal of the Heart Team · 2025
    Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Mitral Interventions in Heart Failure.JACC. Heart failure · 2023
    Review
  15. Early outcomes of transcatheter mitral valve replacement with the Tendyne system in severe mitral annular calcification.EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology · 2022
    Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 8 institutions in 1 country.

Estefanía Fernández-PeregrinaDepartment of Cardiology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Isaac PascualHeart Area, Hospital Universitario Central de Asturias, Oviedo, Spain.
Xavier FreixaHospital Clinic de Barcelona, Institut Clinic Cardiovascular, Barcelona, Spain.
Gabriela Tirado-ConteCardiovascular Institute, Hospital Clinico San Carlos, IdISSC, Madrid, Spain.
Rodrigo Estévez-LoureiroInterventional Cardiology Unit, Hospital Álvaro Cunqueiro, Vigo, Spain.
Fernando Carrasco-ChinchillaHospital Clínico Universitario Virgen de la Victoria, CIBERCV, Málaga, Spain.
Tomás Benito-GonzálezDepartment of Cardiology, University Hospital of León, León, Spain.
Lluis AsmaratsDepartment of Cardiology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Laura SanchísHospital Clinic de Barcelona, Institut Clinic Cardiovascular, Barcelona, Spain.
Pilar Jiménez-QuevedoCardiovascular Institute, Hospital Clinico San Carlos, IdISSC, Madrid, Spain.
Pablo AvanzasHeart Area, Hospital Universitario Central de Asturias, Oviedo, Spain.
Berenice Caneiro-QueijaInterventional Cardiology Unit, Hospital Álvaro Cunqueiro, Vigo, Spain.
Ana Isabel Molina-RamosHospital Clínico Universitario Virgen de la Victoria, CIBERCV, Málaga, Spain.
Felipe Fernández-VázquezDepartment of Cardiology, University Hospital of León, León, Spain.
Chi-Hion LiDepartment of Cardiology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Eduardo Flores-UmanzorHospital Clinic de Barcelona, Institut Clinic Cardiovascular, Barcelona, Spain.
Jordi Sans-RosellóDepartment of Cardiology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Luis Nombela-FrancoCardiovascular Institute, Hospital Clinico San Carlos, IdISSC, Madrid, Spain.
Dabit ArzamendiDepartment of Cardiology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Hospital de Sant Pau · ESHospital Clínic de Barcelona · ESHospital de León · ESHospital Universitario Central de Asturias · ESInstituto de Investigación Sanitaria del Hospital Clínico San Carlos · ESUniversity Hospital Complex Of Vigo · ESHospital Clínico San Carlos · ESUniversitat Autònoma de Barcelona · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMAC is commonly found in patients affected with MR, and it is associated with high morbidity, mortality and worse cardiac surgical outcomes. Transcatheter edge-to-edge repair could be an alternative treatment, although there is little evidence in this population.

aimsThe aim of this study was to analyse the safety, efficacy and durability of MitraClip implantation in patients affected with mitral regurgitation (MR) and mitral annulus calcification (MAC).

methodsWe analysed the outcomes of 61 suitable patients affected with severe MR and moderate or severe MAC (the "MAC" group) and 791 patients with no or mild MAC (the "NoMAC" group) treated with the MitraClip device.

resultsProcedural success was similar (91.8% vs 95.1%, p=0.268, in MAC and NoMAC, respectively), with a very low rate of complications. At one-year follow-up, 90.6% of MAC and 79.5% of NoMAC patients had MR grade ≤2 (p=0.129), 80% in both groups remained in NYHA Functional Class ≤II, and a significant reduction in cardiac readmissions was observed (65% vs 78% in MAC vs NoMAC, p=0.145). One-year mortality tended to be higher in MAC patients (19.7% vs 11.3%, p=0.050), with no difference in cardiovascular mortality (15.3% vs 9.2%, p=0.129).

conclusionsMitraClip use in selected patients with moderate or severe MAC is safe, feasible and achieves good clinical and echocardiographic results at one-year follow-up.

Indexed as

Cardiac Surgical ProceduresHeart Valve Prosthesis ImplantationMitral Valve InsufficiencyCardiac CatheterizationHumansMitral ValveSeverity of Illness IndexTreatment Outcome

Identifiers

PMID34483091
PMCPMC9743252
OpenAlexW3198793972

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.